Isomorphic Labs said on Nov. 17, 2026 that it raised $5 billion in a Series C co-led by Greenoaks and Sequoia Capital, with Andreessen Horowitz and other new investors, plus continued significant investment from Alphabet. Thrive Capital, MGX, GV, CapitalG, Temasek, and the UK Sovereign AI Fund also participated. The company said the round will scale its IsoDDE drug-design engine and candidate pipeline. The announcement does not state a valuation or Alphabet's check size.
/ Sources
/ About this story
Compiled by Venture Atlas from the sources above, using automated AI-assisted research. This is a summary of reporting published elsewhere, not original reporting - follow the source links for the full account. See our editorial standards.
Something wrong here? Email apostructura@gmail.com and we will fix it.
/ Related
- Google agrees to buy 50 MW of Oregon geothermal powerTuesday, November 17, 2026
- MLCommons releases Training v6.1 with first Rubin resultsTuesday, November 17, 2026
- Commerce releases a remote-access rule for advanced AI chipsMonday, November 16, 2026
- Google says attackers automated exploit writing without a person in the loopMonday, November 16, 2026

